A detailed history of Qube Research & Technologies LTD transactions in Petmed Express Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 57,415 shares of PETS stock, worth $217,028. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,415
Previous 98,649 41.8%
Holding current value
$217,028
Previous $472,000 50.85%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$3.95 - $4.84 $162,874 - $199,572
-41,234 Reduced 41.8%
57,415 $232,000
Q1 2024

May 14, 2024

SELL
$4.7 - $7.58 $1.21 Million - $1.95 Million
-257,247 Reduced 72.28%
98,649 $472,000
Q4 2023

Feb 13, 2024

BUY
$6.89 - $11.04 $866,031 - $1.39 Million
125,694 Added 54.6%
355,896 $2.69 Million
Q3 2023

Nov 13, 2023

SELL
$10.21 - $14.65 $1.19 Million - $1.71 Million
-116,929 Reduced 33.68%
230,202 $2.36 Million
Q2 2023

Aug 14, 2023

BUY
$13.68 - $16.56 $4.57 Million - $5.53 Million
334,161 Added 2576.41%
347,131 $4.79 Million
Q1 2023

May 15, 2023

SELL
$15.9 - $22.22 $1.07 Million - $1.49 Million
-67,186 Reduced 83.82%
12,970 $210,000
Q4 2022

Feb 14, 2023

BUY
$17.16 - $22.14 $1.13 Million - $1.46 Million
65,952 Added 464.32%
80,156 $1.42 Million
Q3 2022

Nov 14, 2022

BUY
$19.35 - $23.52 $274,847 - $334,078
14,204 New
14,204 $277,000
Q1 2021

May 14, 2021

SELL
$29.77 - $51.8 $375,995 - $654,234
-12,630 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$28.96 - $33.77 $150,331 - $175,300
5,191 Added 69.78%
12,630 $405,000
Q3 2020

Nov 12, 2020

SELL
$29.0 - $41.83 $256,070 - $369,358
-8,830 Reduced 54.28%
7,439 $235,000
Q2 2020

Aug 14, 2020

BUY
$27.94 - $40.96 $10,617 - $15,564
380 Added 2.39%
16,269 $580,000
Q1 2020

May 15, 2020

BUY
$22.18 - $28.78 $352,418 - $457,285
15,889 New
15,889 $457,000

Others Institutions Holding PETS

About PETMED EXPRESS INC


  • Ticker PETS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Pharmaceutical Retailers
  • Shares Outstandng 21,013,800
  • Market Cap $79.4M
  • Description
  • PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint c...
More about PETS
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.